Skip to content

Co-crystallization of Diclofenac with Caffeine Anhydrous to Enhance Aqueous Solubility

Oct 2026 · Asian Journal of Pharmaceutical Research · 0 citations · 8 references

Abstract

Introduction: Aqueous solubility is a critical determinant of the bioavailability and therapeutic efficacy of orally administered drugs, particularly for those classified under BCS Class II and IV. Diclofenac, BCS Class-II drug suffers from poor aqueous solubility, leading to low bioavailability and variable therapeutic outcomes. Objectives: This study explores the use of co-crystallization techniques as an approach to enhance the solubility of diclofenac by using anhydrous caffeine as co-former, also known for its synergistic effects with diclofenac. Methods: Co-crystals of diclofenac sodium and anhydrous caffeine were prepared using five distinct methods: neat grinding, solvent-assisted grinding, crystallization by melting, solvent evaporation, and anti-solvent approaches. The co-crystals were characterized using infrared spectroscopy, melting point analysis, X-ray diffraction, and DSC. Solubility studies were conducted to evaluate the enhancement in aqueous solubility. Results: Characterization studies confirmed the successful formation of co-crystals through all five methods. The co-crystals exhibited reduced melting points compared to pure diclofenac sodium, indicating enhanced solubility. IR spectroscopy revealed shifts in characteristic peaks, suggesting the formation of hydrogen bonds and other non-covalent interactions. XRPD analysis confirmed changes in crystallinity, with a trend toward amorphous characteristics. Solubility studies demonstrated a significant increase in the aqueous solubility of diclofenac co-crystals, with the solvent-assisted grinding method yielding the highest solubility of 66mg/ml, compared to 13.62mg/ml for pure diclofenac sodium. Discussion and Conclusion: The solvent-assisted grinding method proved to be the most effective, producing co-crystals with the better solubility. These findings highlight the potential of co-crystallization as a viable approach to address the solubility challenges associated with poorly soluble drugs like diclofenac and offering a promising strategy to improve bioavailability and reduce dosage requirements.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.